Personalised nutrition – nutrition recommendations tailored to individual genetic profiles, microbiome composition, biomarkers, and health goals – is creating a new category in the health and wellness market. Nutrigenomics companies, microbiome testing platforms, custom supplement manufacturers, AI-powered diet coaching apps, and corporate nutrition wellness programmes are all evaluating new market entry opportunities as consumer interest in personalised health approaches grows. GreyRadius helps personalised nutrition businesses validate consumer demand, navigate regulatory frameworks, execute GTM plans, and raise capital.
Why now? Consumer adoption of genetic testing and health biomarker monitoring is at an inflection point – the normalisation of direct-to-consumer genetic testing through 23andMe and similar companies has created consumer familiarity with personalised health data. The Gulf's premium health consumer segment and Singapore's preventive health infrastructure create near-term high-value markets for personalised nutrition businesses.
Global personalised nutrition market is projected to reach $16B by 2028 – growing at 15% annually as genetic testing costs fall, microbiome research advances, and AI-powered nutrition coaching achieves consumer adoption.
Corporate personalised wellness programmes are growing at 20%+ annually – employers in Singapore, the Gulf, and India are investing in personalised nutrition programmes as part of executive health and employee wellness benefits.
Microbiome-based nutrition recommendations are gaining clinical validation – gut microbiome testing companies are accumulating clinical evidence that microbiome composition predicts nutritional response, creating a science-backed product category.
AI-powered dietary coaching is reducing the cost of personalised nutrition – AI apps that provide personalised meal planning and nutritional guidance based on health data are making personalised nutrition accessible beyond HNW consumers.
If you recognise your situation below, we can help.
Consumer demand validation
You need to validate that consumers in your target market are interested in personalised nutrition and willing to pay the premium pricing the service requires.
Regulatory classification and pathway
You need to understand how your personalised nutrition service – genetic testing, microbiome analysis, custom supplements – is classified in your target market.
Corporate wellness buyer strategy
You need to identify HR directors and employee wellness programme managers who are allocating budget to personalised nutrition benefits.
GTM for a personalised nutrition platform
You have a genetic nutrition, microbiome, or AI diet coaching product and need a go-to-market strategy.
Raising capital for a personalised nutrition venture
You are raising investment and need a pitch book grounded in consumer demand data and scientific validation.
Scientific validation and clinical partnership strategy
You need to identify research hospitals and nutrition science institutions as clinical validation and marketing credibility partners.
Every engagement is grounded in primary research and delivers a measurable outcome.
Validate consumer and corporate demand for personalised nutrition in a new market. Covers consumer surveys, HR wellness buyer interviews, regulatory mapping, and a Go/Defer/Kill recommendation.
Learn more →Full financial and operational feasibility for personalised nutrition platform launches. Covers consumer demand modelling, unit economics, supply chain cost, and investor-ready projections.
Learn more →End-to-end market entry for personalised nutrition companies. Regulatory pathway, corporate wellness channel development, consumer ICP, and first-client acquisition.
Learn more →Embedded GTM team for personalised nutrition platforms. Consumer acquisition execution, corporate wellness pipeline, and first-revenue milestone tracking.
Learn more →Investor-ready pitch books for personalised nutrition ventures. Consumer-demand-validated market sizing, scientific narrative, and investor identification.
Learn more →AI use-case prioritisation in personalised nutrition – from nutrigenomics analysis and dietary pattern recognition to personalised meal planning and supplement formulation optimisation.
Learn more →80% of our insight comes from first-party interviews with buyers, competitors, and regulators – not secondary data that everyone else has.
Our AI layer compresses research timelines by 60% and surfaces pattern-matching from 200+ prior mandates – so you get faster, deeper answers.
We measure success by first contracts signed, capital raised, and markets entered – not deliverables produced. Every mandate has a milestone.
200+
Projects delivered
100+
SaaS & tech clients
80%
Primary research-led
4
Countries / offices
Health Supplements · Market Entry
Health Supplements · GTM
Health Supplements · Feasibility
All three. We work across nutrigenomics, microbiome testing, custom supplement manufacturing, and AI dietary coaching on market entry, GTM, and fundraising.
Gulf, Southeast Asia, and South Asia – markets with premium health consumer segments and growing corporate wellness investment.
Typically 6–10 weeks for consumer demand research, regulatory mapping, and market entry strategy.
Yes. Corporate wellness buyer identification and initial commercial conversations are part of our GTM Execution-as-a-Service.
GreyRadius research notes, market entry signals, and sector briefs – delivered weekly. No fluff.
Not sure which engagement fits? Take our free 2-minute diagnostic →
Primary research. AI-enabled analysis, expert-reviewed. Outcomes-based delivery – across Gulf, Southeast Asia, South Asia.
